Science - Top Stories latest news

A handful of the world's largest agricultural biotechnology companies are seeking hundreds of patents on gene-altered crops designed to withstand drought and other environmental stresses, part of a race for dominance in the potentially lucrative market for crops that can handle global warming,...

The WorldWide Telescope allows anyone to see stars and planets thousands of light-years away.

A new breed of tinkerers mix science and craft to make things both goofy and grand.

AP - Two decades from now Americans could get as much electricity from windmills as from nuclear power plants, according to a government report that lays out a possible plan for wind energy growth.

SEATTLE (Reuters) - Any Star Trek fan knows that space travel is not always easy, but Microsoft Corp wants to make traveling the "final frontier" as simple as turning on your computer.

A study to determine whether chronic disease management of individuals with diabetes and/or congestive heart failure improves health outcome and lowers healthcare costs trial provides the first scientifically valid look at what one might expect from chronic disease management programs that serve low-income individuals.

NEW YORK (AP) -- News that scientists have for the first time genetically altered a human embryo is drawing fire from some watchdog groups that say it's a step toward creating "designer babies."...

Promising results from a team of NewYork-Presbyterian Hospital/Weill Cornell medical Center physician-scientists show that gene therapy is both safe and effective at slowing the progression of Batten disease, or Late Infantile Neuronal Ceroid Lipofuscinosis, a rare, genetic, degenerative neurological disorder that usually becomes fatal in children by the age of 8 to 12.

Much has been made about Facebook's $15 billion valuation, but when will it start making some actual profits? Mike Murphy, the social net's VP of media sales, tells USAT that's the question he gets asked most often.

Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children, according to a paper published online ahead of print in the May 2008 issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.